DOUGLAS JAY SPRUNG, M.D.
Sulindac, one of the newer nonsteroidal anti-inflammatory agents, has gained popularity because it can be taken twice a day and has few adverse effects. Reactions to sulindac include hepatotoxicity (1), bone marrow aplasia (2), acute febrile hypersensitivity reactions (3, 4), and Stevens-Johnson syndrome (5). More common side effects include nausea, vomiting, rashes, and headaches. This report describes a febrile hypersensitivity reaction with concomitant splenomegaly and mediastinal as well as general peripheral lymphadenopathy.
A 61-year-old white man presented with a 10-day history of headache, fever, rash, malaise, and lymphadenopathy. This condition had occurred 1 year earlier, lasting 6 weeks, with complete
DOUGLAS JAY SPRUNG. Sulindac Causing a Hypersensitivity Reaction with Peripheral and Mediastinal Lymphadenopathy. Ann Intern Med. 1982;97:564–565. doi: 10.7326/0003-4819-97-4-564
Download citation file:
Published: Ann Intern Med. 1982;97(4):564-565.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use